Azenta, Inc.
Congressional Trades
Whale Activity
- Increased75
- New50
- Held45
- Decreased87
- Closed24
- No prior filing13
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 7.0M | $244.8M | decreased |
| Politan Capital Management LP | 4.6M | $161.3M | held |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.4M | $84.9M | decreased |
| STATE STREET CORP | 1.8M | $62.2M | decreased |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.7M | $60.8M | decreased |
| DIMENSIONAL FUND ADVISORS LP | 1.2M | $41.8M | decreased |
| MORGAN STANLEY | 1.1M | $40.0M | decreased |
| D. E. Shaw & Co., Inc. | 1.1M | $39.5M | decreased |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1M | $38.6M | increased |
| Neuberger Berman Group LLC | 1.0M | $35.1M | decreased |
| GW&K Investment Management, LLC | 992.6K | $34.6M | increased |
| VICTORY CAPITAL MANAGEMENT INC | 797.2K | $27.8M | decreased |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Recent Insider Transactions
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Madaus Martin DInterim CEO | Tax withholding | −1,456 | $34.28 | $50K | Sep 22, 2026 | Form 4 ↗ |
| Bello Erik J.VP Chief Accounting Officer | Grant / award | +4,586 | $0.00 | $0 | Sep 15, 2026 | Form 4 ↗ |
| Madaus Martin DInterim CEO | Grant / award | +36.7K | $0.00 | $0 | Sep 14, 2026 | Form 4 ↗ |
| MARTIN WILLIAM E. IIIPresident Multiomics | Grant / award | +15.3K | $0.00 | $0 | Sep 14, 2026 | Form 4 ↗ |
| Pirogova OlgaSVP and CHRO | Grant / award | +15.3K | $0.00 | $0 | Sep 14, 2026 | Form 4 ↗ |
| Lin Lawrence Y.EVP, CFO and Treasurer | Grant / award | +30.5K | $0.00 | $0 | Sep 14, 2026 | Form 4 ↗ |
| Starr EphraimSVP, Gen Counsel & Secretary | Grant / award | +15.3K | $0.00 | $0 | Sep 14, 2026 | Form 4 ↗ |
| Pirogova OlgaSVP and CHRO | Tax withholding | −1,085 | $32.04 | $35K | Aug 9, 2026 | Form 4 ↗ |
| Starr EphraimSVP, Gen Counsel & Secretary | Purchase | +335 | $24.17 | $8K | Jul 31, 2026 | Form 4 ↗ |
| Cornog William LDirector | Purchase | +10.0K | $16.38 | $164K | May 18, 2026 | Form 4 ↗ |
| Starr EphraimSVP, Gen Counsel & Secretary | Tax withholding | −3,621 | $16.02 | $58K | May 15, 2026 | Form 4 ↗ |
| MARTIN WILLIAM E. IIIPresident Multiomics | Grant / award | +17.8K | $24.24 | $431K | Apr 28, 2026 | Form 4 ↗ |
| Nova Tina SusanDirector | Grant / award | +5,663 | $27.85 | $158K | Feb 6, 2026 | Form 4 ↗ |
| Koffey QuentinDirector | Grant / award | +5,663 | $0.00 | $0 | Feb 5, 2026 | Form 4 ↗ |
| Doshi DipalDirector | Grant / award | +5,663 | $27.85 | $158K | Feb 5, 2026 | Form 4 ↗ |
| Casal FrankDirector | Grant / award | +7,243 | $27.85 | $202K | Feb 5, 2026 | Form 4 ↗ |
| McLaughlin EricaDirector | Grant / award | +5,663 | $27.85 | $158K | Feb 5, 2026 | Form 4 ↗ |
| Marotta JohnPresident and CEO · Director | Grant / award Amended | +118.2K | $0.00 | $0 | Nov 24, 2025 | Form 4 ↗ |
| Marotta JohnPresident and CEO · Director | Grant / award | +122.3K | $0.00 | $0 | Nov 24, 2025 | Form 4 ↗ |
| Lin Lawrence Y.EVP, CFO and Treasurer | Grant / award | +36.7K | $0.00 | $0 | Nov 24, 2025 | Form 4 ↗ |
Fund Holders
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF iShares Trust | 2.5M | $63.1M | 0.06% | Jun 30, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 1.3M | $33.7M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF iShares Trust | 1.1M | $28.0M | 0.03% | Jun 30, 2026 |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 950.4K | $24.3M | 0.01% | Jun 30, 2026 |
| VANGUARD SMALL-CAP VALUE INDEX FUND VANGUARD INDEX FUNDS | 602.7K | $15.4M | 0.02% | Jun 30, 2026 |
| MFS New Discovery Value Fund MFS SERIES TRUST XIII | 439.7K | $14.4M | 0.63% | Aug 31, 2026 |
| Columbia Small Cap Value Discovery Fund COLUMBIA FUNDS SERIES TRUST I | 486.2K | $13.7M | 0.55% | Jul 31, 2026 |
| Allspring Special Small Cap Value Fund ALLSPRING FUNDS TRUST | 519.6K | $13.3M | 0.45% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 460.0K | $12.9M | 0.04% | Jul 31, 2026 |
| VANGUARD EXPLORER FUND | 525.8K | $12.9M | 0.06% | Apr 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list AZTA's shares (CUSIP 114340102), each fund at its latest report since Apr 22, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
No lobbying filings found naming Azenta, Inc. as the client.
Government Contracts
No federal contract awards found for Azenta, Inc..
U.S. Patents
No USPTO patent applications found for Azenta, Inc..
Annual Financials
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $593.8M | $573.4M | $551.5M | $555.5M | $513.7M |
| Operating income | -$26.8M | -$51.3M | -$61.2M | -$24.7M | -$31.1M |
| Net income | -$55.8M | -$164.9M | -$14.6M | $2.13B | $110.7M |
| Diluted EPS | -$1.22 | -$3.10 | -$0.22 | $28.48 | $1.49 |
| Operating cash flow | $72.2M | $49.7M | $5.8M | -$466.0M | $149.9M |
| Cash and equivalents | $279.8M | $280.0M | $649.5M | $658.3M | $227.4M |
| Total assets | $2.06B | $2.10B | $2.89B | $3.72B | $1.82B |
| Total liabilities | $332.6M | $332.4M | $351.2M | $352.7M | $494.2M |
| Shareholders' equity | $1.73B | $1.77B | $2.53B | $3.36B | $1.33B |
As Azenta, Inc. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Dec 4, 2025 ↗
Stock Splits
No stock splits in AZTA's price history.
Material Events (8-K)
- 8-K · Items 2.02, 9.01Results of operationsNov 10, 2026
EDGAR ↗ - 8-K · Items 1.01, 7.01, 8.01Material agreement · Reg FD disclosure · Other eventsOct 30, 2026
EDGAR ↗ - 8-K · Items 2.05, 2.06, 9.01Exit or disposal costs · Material impairmentsOct 7, 2026
EDGAR ↗ - 8-K · Items 5.02, 9.01Officer / director changeSep 17, 2026
EDGAR ↗ - 8-K · Items 7.01, 8.01, 9.01Reg FD disclosure · Other eventsSep 4, 2026
EDGAR ↗ - 8-K · Items 5.02, 7.01Officer / director change · Reg FD disclosureAug 24, 2026
EDGAR ↗ - 8-K · Items 5.02, 9.01Officer / director changeAug 11, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsAug 4, 2026
EDGAR ↗ - 8-K · Items 1.01, 2.01, 7.01, 9.01Material agreement · Acquisition or disposition · Reg FD disclosureJul 8, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsMay 5, 2026
EDGAR ↗
About Azenta, Inc.
Overview We are a leading global provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. We entered the life sciences market in 2011, leveraging our in-house precision automation and cryogenics capabilities that we were then applying in the semiconductor manufacturing market. This led us to develop and provide solutions for automated ultra-cold storage. Since then, we have expanded our life sciences offerings through internal investments and through a series of acquisitions. We support our customers from research and clinical development to commercialization with our sample management and automated storage systems, as well as g…


